Ontario reports 1st fatal case of rare blood clot from AstraZeneca COVID-19 vaccine | FULL

The Ontario government has reported the first fatal case of an extremely rare blood clot that has been detected in a small number of residents who received the AstraZeneca/COVISHEILD COVID-19 vaccine.

Dr. Barbara Yaffe, Ontario’s associate chief medical officer of health, made the announcement during a news conference at Queen’s Park Tuesday afternoon.

She said a man in his 40s developed vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving his first dose of the vaccine at the end of April and died a few weeks later.

“While the investigation is ongoing and a final cause of death has yet to be officially determined, it has been confirmed the official did have VITT at the time of his death,” Yaffe told reporters.

For more info, please go to https://globalnews.ca/news/7891969/covid-ontario-vitt-astrazeneca-vaccine/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Coronavirus #COVID19 #Ontario #GlobalNews